Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio

Pain Management


Cancer Pain Management


A Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio


Benítez-Rosario MA, Salinas-Martín A, González-Guillermo T, et al (Univ Hosp La Candelaria, Tenerife, Spain; et al) J Pain Symptom Manage 41:1098-1105, 2011§



S.E. Abram, MD



Evidence Ranking


• B



Expert Rating


• 2



Abstract







Conclusion


A 1:1 dose ratio for conversion from s.c. to oral ketamine is safe and effective in cancer pain patients (Fig 1, Tables 2 and 4).


Stay updated, free articles. Join our Telegram channel

Jan 28, 2017 | Posted by in ANESTHESIA | Comments Off on Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio

Full access? Get Clinical Tree

Get Clinical Tree app for offline access